X-Change Corporation Appoints Maliseet Nation Councilor Gerald Bear to Facilitate Agreement with Maliseet Nation, Oversee the Development & Operations of the Medical Treatment Center, Clinical Laboratory, Manufacturing & Production Facility, and Cannabis Grow Facility
DALLAS, Feb. 15, 2013 /PRNewswire/ — X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services, proudly announces the appointment of Maliseet Nation Councilor Gerald Bear to oversee the Maliseet Nation Agreement with XCHC.
Councilor Gerald Bear’s initial responsibilities include the setup, oversight, and operations management of the Maliseet Nation facilities, such as its legally compliant cannabis growing facility, clinical laboratory, manufacturing and production facility, and treatment center along with all political and regulatory matters related to these facilities.
Councilor Bear will also ensure that the development and operations activities of the facilities remain in complete compliance with all international, federal, and provincial laws as well as entering discussions and agreement facilitating with other First Nations across Canada so that treatment centers are geographically convenient for patients across the Country, which will allow multiple access points for international travelers seeking immediate treatments for their loved ones with critical ailments.
“I am really impressed with Councilor Bear and his vision of the Maliseet Nation facility. Gerald has the ability not only to implement this program properly but also to take the program to the highest levels of integrity and quality needed for it to be accepted by the global medical community, as the Company enters into agreements with other First Nations to establish similar facilities. More importantly, we are proud to be part of something that has the potential to help so many people and improve their quality of life,” stated Robert Kane, President of X-Change Corporation.
The Maliseet Nation Agreement
This Historical agreement allows for legal cannabis and hemp-based medical research and treatments with true global significance, as the operations under the Agreement facilitate medical cannabis and hemp research, pre-clinical trials, and treatments, among numerous other opportunities for the parties to the Agreement, for the first time in North America. And these unique operations, including medical treatments, will be open to the citizens of the world in a legal manner. The sovereignty of the Maliseet Nation allows this venture to accomplish its goals of helping patients while being legally compliant.
About The X-Change Corporation and its Phytiva Brand of Products
X-Change Corp. is U.S. Boutique Company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. These new Phytiva product lines will be launched with cannabis based formulations through medical cannabis dispensaries, cannabis laboratories, and individual legal state or legal foreign grow operations on a jurisdiction by jurisdiction approved basis in accordance with existing laws.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements might not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
President & CEO
SOURCE X-Change Corp